NationofChange UK regulators give okay to use psychedelic drug to treat depression in first clinical trial "We think this could be a treatment for a number of depressive disorders besides major depression, including PTSD, treatment-resistant depression, obsessive-compulsive disorder, and possibly some types of substance abuse." Dimethyltriptamine, a psychedelic drug, will soon be trial-led in the United Kingdom to treat depression. UK Regulators will begin the trial by giving the “spirit molecule” drug to healthy individuals and then follow it up with a second trial on patient...